Edition:
United Kingdom

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,512JPY
7:00am BST
Change (% chg)

¥-4 (-0.26%)
Prev Close
¥1,516
Open
¥1,518
Day's High
¥1,526
Day's Low
¥1,503
Volume
2,917,000
Avg. Vol
6,359,574
52-wk High
¥2,056
52-wk Low
¥1,356

Yasukawa, Kenji 

Mr. Kenji Yasukawa has been serving as President, Chief Executive Officer and Representative Director in Astellas Pharma Inc. since April 1, 2018. He joined the Company in April 1986. His previous titles include Vice President, Executive Officer, Senior Executive Officer and Director of Product Strategy in the Company. He used to work for Yamanouchi Pharmaceutical Co., Ltd. and a subsidiary.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --